Uncategorized
Second Sight Reports Third Quarter 2016 Financial Results
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide a form of useful vision to blind patients, today reported financial results for the three- and nine-month periods ended September 30, 2016. Recent Company Highlights: Implanted 14 Argus® II Retinal Prosthesis Systems (Argus II) worldwide during the third quarter of 2016 compared to 15 implants in
